Streamlining Radioembolization for Small HCC
ConditionHepatocellular Carcinoma (HCC)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorSeoul National University Hospital
About this trial
In patients who has no sign suggesting high lung shunt fraction (TIPS, hepatic vein invasion, hepatic vein enhancement on arterial phase, dysmorphic intratumoral vessel, tumor size \< 5cm), radioembolization is performed without MAA scan with SIR-Spheres. This prospective registry will prove that the selection criteria is accurate and streamlining radioembolization is feasible and safe.
Eligibility criteria
Qualifiers
adults aged >18 years
Patients diagnosed with hepatocellular carcinoma histologically and/or radiologically (LI-RADS 4 or 5)
hepatocellular carcinoma 5cm or smaller
Tumor number is 3 or smaller
Disqualifiers
Hepatic vein invasion on CT/MRI
Marked enhancement of portal vein or hepatic vein on arterial phase of CT/MRI
Dysmorphic intratumoral vessel ≥3mm
Patient with transjugular intrahepatic portosystemic shunt
Trial design
Treatments tested in this trial
- Not listed
Trial groups
146 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov